Chubu-Rosai Hospital
Nagoya, Aichi, Japan
General hospital in Nagoya
1 Chome-10番6号 Komei, Minato Ward, Nagoya, Aichi 455-8530
About Chubu-Rosai Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
5
Eli Lilly and Company
3
Janssen Research & Development, LLC
2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2
ASKA Pharmaceutical Co., Ltd.
1
Bayer
1
Daiichi Sankyo Co., Ltd.
1
Kowa Company, Ltd.
1
Millennium Pharmaceuticals, Inc.
1
Takeda
1
Clinical Trials at Chubu-Rosai Hospital
During the past decade, Chubu-Rosai Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 5 clinical trials were completed, i.e. on
average, 35.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 3 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure
2010-07-01
2015-09-01
Completed
221
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
2010-09-01
2012-03-01
Completed
104
An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis
2013-06-27
2020-11-12
Completed
2,877
Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS)
2014-11-27
2018-08-14
Completed
5,390
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
2018-10-14
2021-07-15
Completed
242
EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)
2019-01-31
2025-01-31
Active, not recruiting
6,609
A Study of JNJ-70033093 (BMS-986177) Versus Subcutaneous Enoxaparin in Participants Undergoing Elective Total Knee Replacement Surgery
2019-06-17
2021-04-06
Completed
1,242
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Chubu-Rosai Hospital" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Eli Lilly and Company" with 3 trials
sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "ASKA Pharmaceutical Co., Ltd."
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Chubu-Rosai Hospital"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Chubu-Rosai Hospital
According to Clinical.Site data, the most researched conditions in "Chubu-Rosai Hospital" are
"Chronic Kidney Disease" (2 trials), "Rheumatoid Arthritis" (2 trials), "Alzheimer Disease" (1 trials), "Arthritis" (1 trials) and "Arthroplasty, Replacement, Knee" (1 trials). Many other conditions were trialed in "Chubu-Rosai Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Chubu-Rosai Hospital
Most popular intervention types in "Chubu-Rosai Hospital" are "Drug" (18 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "BI 685509" (2 trials), "Empagliflozin" (2 trials), "ASA 100 mg" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chubu-Rosai Hospital
The vast majority of trials in "Chubu-Rosai Hospital" are
17 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Chubu-Rosai Hospital
Currently, there are NaN active trials in "Chubu-Rosai Hospital".
undefined are not yet recruiting,
5 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Chubu-Rosai Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Chubu-Rosai Hospital, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".